BRIEF-Bristol-Myers announces data for Opdivo and Opdivo plus Yervoy in previously treated small cell lung cancer
October 16, 2017 at 03:21 AM EDT
* Bristol-Myers Squibb Co announced data evaluating Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab) in previously treated small cell lung cancer